期刊
INTERNAL MEDICINE
卷 60, 期 3, 页码 463-468出版社
JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.5646-20
关键词
multiple myeloma; central nerves system; pomalidmide; intrathecal chemotherapy; craniospinal radiation
Limited reports have discussed the central nervous system involvement in multiple myeloma (MM), which has poor prognosis due to resistance to treatments. This case study presented a 45-year-old female patient who experienced CNS relapse after autologous hematopoietic stem cell transplantation, proposing the potential benefit of immunomodulatory drugs against CNS involvement.
Few reports have so far described central nervous system (CNS) involvement in multiple myeloma (MM), which shows a poor prognosis owing to its resistance to several treatments. We herein describe a 45-year-old woman who had MM (diagnosed with IgA-ic type) with CNS relapse early after undergoing autologous hematopoietic stem cell transplantation. Because no standard treatment for CNS lesions of MM has been established, we conducted a literature review on the cerebrospinal fluid (CSF) transferability of drugs for MM, since it was considered to be a useful tool for CNS involvement. Immunomodulatory-drugs including pomalidomide exhibit a good CSF transfer ability, and, therefore, may be beneficial against the CNS involvement of MM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据